Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Free Cash Flow (2016 - 2025)

Orthofix Medical's Free Cash Flow history spans 16 years, with the latest figure at $16.8 million for Q4 2025.

  • For the quarter ending Q4 2025, Free Cash Flow rose 10.67% year-over-year to $16.8 million, compared with a TTM value of -$1.3 million through Dec 2025, up 85.92%, and an annual FY2025 reading of -$1.3 million, up 85.92% over the prior year.
  • Free Cash Flow for Q4 2025 was $16.8 million at Orthofix Medical, up from $2.5 million in the prior quarter.
  • The five-year high for Free Cash Flow was $16.8 million in Q4 2025, with the low at -$45.5 million in Q1 2023.
  • Average Free Cash Flow over 5 years is -$7.6 million, with a median of -$5.5 million recorded in 2022.
  • Year-over-year, Free Cash Flow crashed 577.65% in 2022 and then soared 718.85% in 2025.
  • Tracing OFIX's Free Cash Flow over 5 years: stood at $5.6 million in 2021, then plummeted by 183.78% to -$4.7 million in 2022, then plummeted by 395.36% to -$23.0 million in 2023, then skyrocketed by 165.94% to $15.2 million in 2024, then grew by 10.67% to $16.8 million in 2025.
  • Per Business Quant, the three most recent readings for OFIX's Free Cash Flow are $16.8 million (Q4 2025), $2.5 million (Q3 2025), and $4.5 million (Q2 2025).